Eliot Ward - January 13, 2025

UPC Weekly - Alexion v Samsung & Amgen – Patentee’s attempted U-turn on claim interpretation foiled by UPC Court of Appeal

2025 Week 2 Tailoring one’s claim interpretation for the jurisdiction at hand can be a canny way of ...

Eliot Ward - November 13, 2024

Cambiotics: a novel treatment for PFAS ‘forever chemicals’

PFAS are toxic pollutants causing health problems globally. There is currently no treatment. Now a ...

Matthew Naylor - November 4, 2024

UPC Weekly - All of the fizz and none of the squeeze

2024 Week 44 SodaStream v Aarke is a decision on the merits of an infringement case based on EP ...

Matthew Naylor - October 28, 2024

UPC Weekly - UPC confirms approach to inventive step for life science inventions

2024 Week 43 10x Genomics and NanoString have been duking it out at the UPC since the court opened ...

Eliot Ward - July 3, 2024

Inside the Asian microbiome library

AMILI co-founder Dr Jeremy Lim takes us on a tour of his remarkable lab, where the mysteries of the ...

Eliot Ward - June 14, 2024

How helpful are biological deposits at the EPO?

In our article about biological deposits under the Budapest Treaty, we explored the deadlines and ...

Eliot Ward - June 5, 2024

Unitary patent and UPC to cover Romania from 1 September 2024

The first enlargement of the UPC and Unitary Patent (UP) territory will happen on 1 September 2024, ...

Matthew Naylor - April 29, 2024

UPC Weekly - Battling the Biosimilars: opt-outs, preliminary injunctions & protective letters

2024 Week 17 This week we delve into the details of the first two UPC disputes involving ...

Eliot Ward - February 29, 2024

The link between the microbiome and chronic liver disorders

Guts UK is the charity for the digestive system. It funds scientific research such as Nicholas ...

Eliot Ward - February 21, 2024

Biological Deposits under the Budapest Treaty (1977): important considerations for filing strategies and public accessibility

Biological material, which the EPO understands to be any material containing genetic information ...

Eliot Ward - October 4, 2023

UPC at four months old - a review

The UPC is now four months old and the Court of First Instance is already quite busy. As of 4 ...

Eliot Ward - May 4, 2023

The ball is rolling at the FDA for microbiome therapies

The FDA was busy last week! Off the back of the first approval for faecal microbiota transplant ...

Natalie Vaughan - February 23, 2023

Microbiome claims around the world: how to define your microbe?

A booming commercial interest in harnessing the human microbiome for therapeutic uses has led to a ...

Eliot Ward - February 17, 2023

Germany completes ratification of UPC agreement, confirming the 1 June 2023 launch date

Months of delay and uncertainty are finally behind us. Germany deposited its ratification of the ...

Eliot Ward - December 1, 2022

Welcome to the market, FMT

On Wednesday 30 November 2022, the U.S. Food and Drug Administration (FDA) authorised the first ...

Darena Slavova - November 1, 2022

EPO introduces top-up searches for earlier national rights

On 1 September 2022, the EPO introduced an extra “quality check” prior to granting a European ...

Eliot Ward - September 22, 2022

Mewburn Ellis launch Validation Costs Estimator Tool

We are pleased to launch our new Validation Costs Estimator Tool. We know that it can be ...

Eliot Ward - September 12, 2022

Regulatory challenges for microbiome therapeutics in the EU and beyond – focus on FMT

One of the oldest known microbiome-based therapeutics, faecal microbiota transplantation, is again ...

Eliot Ward - July 19, 2022

Unitary Patent Package - an overview

In this Forward: On Demand vlog, Eliot Ward gives us an overview of the Unitary Patent Package, ...

Eliot Ward - July 7, 2022

Breakthrough: super fast DNA tests

A rapid bedside genetic test can screen newborn babies for a genetic variant which makes them ...

Eliot Ward - January 19, 2022

As the UPC preparatory period begins, the EPO decides to accept UP requests before the full UPC agreement comes into force

  On 18 January 2022, Austria became the thirteenth EU country to ratify the “protocol on ...

Eliot Ward - December 3, 2021

Austrian parliament unanimously passes legislation to allow the practical preparations for the UPC to begin

On 2 December 2021, Austria became the thirteenth EU country to pass the “protocol on provisional ...

Eliot Ward - December 21, 2020

Will the COVID-19 vaccines induce more robust immunity than infection with SARS-Cov-2 itself?

Respiratory viruses such as coronaviruses are notorious for evading the immune system[1] and, in ...

Jacqueline Murphy - October 1, 2020

Mewburn Ellis: top tier firm Legal 500 2021

We are delighted to be ranked top tier for our patent practice in the 2021 edition of The Legal ...

Eliot Ward - April 2, 2020

A*STAR and MiRXES step up in the fight against coronavirus (COVID-19)

Our Singapore based-clients A*STAR (Agency for Science, Technology and Research) and MiRXES are ...

Eliot Ward - March 25, 2020

Microbiome: Meet your multitude

The health and wellbeing of each of us depends upon a number of vast communities of microbes that ...

Eliot Ward - December 6, 2019

Gamma/delta T cells emerge as an untapped resource for cancer immunotherapy

Third lymphocyte lineage shows its mettle B lymphocytes, a type of white blood cell that is ...